Respiratory Morbidity in Prematurely Born Children Receiving Palivizumab Prophylaxis of Respiratory Syncytial Virus Disease.

Autor: Bjelica, Milena1,2 milena.bjelica@mf.uns.ac.rs, Dautović, Gordana Vilotijević1,2, Spasojević, Slobodan1,2, Đermanović, Marija2, Plazačić, Milica2
Zdroj: Iranian Journal of Neonatology. Apr2024, Vol. 15 Issue 2, p3-12. 10p.
Databáze: Academic Search Ultimate